{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T04:18:56Z","timestamp":1779250736654,"version":"3.51.4"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,3,27]]},"DOI":"10.1097\/tp.0b013e318244f774","type":"journal-article","created":{"date-parts":[[2012,1,26]],"date-time":"2012-01-26T11:05:15Z","timestamp":1327575915000},"page":"644-649","source":"Crossref","is-referenced-by-count":40,"title":["Role of IL28B Polymorphism in the Development of Hepatitis C Virus-Induced Hepatocellular Carcinoma, Graft Fibrosis, and Posttransplant Antiviral Therapy"],"prefix":"10.1097","volume":"93","author":[{"given":"Dennis","family":"Eurich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Boas-Knoop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcus","family":"Bahra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth","family":"Neuhaus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajan","family":"Somasundaram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Neuhaus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulf","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Seehofer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"suppl 1","key":"R1-13-20210129","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1038\/sj.cdd.4401163","article-title":". Hepatitis C and liver fibrosis.","volume":"10","author":"Schuppan","year":"2003","journal-title":"Cell Death Differ"},{"key":"R2-13-20210129","doi-asserted-by":"crossref","first-page":"5093","DOI":"10.1038\/sj.onc.1206557","article-title":". Molecular viral oncology of hepatocellular carcinoma.","volume":"22","author":"Block","year":"2003","journal-title":"Oncogene"},{"key":"R3-13-20210129","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/01.TP.0000101738.27552.9D","article-title":". Long-term outcome of liver transplants for chronic hepatitis C: A 10-year follow-up.","volume":"77","author":"Neumann","year":"2004","journal-title":"Transplantation"},{"key":"R5-13-20210129","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/01.tp.0000173645.89064.c7","article-title":". Platelet-derived growth factor gene polymorphism in recurrent hepatitis C infection after liver transplantation.","volume":"81","author":"Ben-Ari","year":"2006","journal-title":"Transplantation"},{"key":"R6-13-20210129","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/lt.22190","article-title":". Transforming growth factor beta1 polymorphisms and progression of graft fibrosis after liver transplantation for hepatitis C virus-induced liver disease.","volume":"17","author":"Eurich","year":"2011","journal-title":"Liver Transpl"},{"key":"R7-13-20210129","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/lt.22235","article-title":". Relationship between the interleukin-28b gene polymorphism and the histological severity of hepatitis C virus-induced graft inflammation and the response to antiviral therapy after liver transplantation.","volume":"17","author":"Eurich","year":"2011","journal-title":"Liver Transpl"},{"key":"R8-13-20210129","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.0009-9163.2004.00208.x","article-title":". Polymorphisms in cytokines and growth factor genes and their association with acute rejection and recurrence of hepatitis C virus disease in liver transplantation.","volume":"65","author":"Mas","year":"2004","journal-title":"Clin Genet"},{"key":"R9-13-20210129","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1365-2893.2008.00965.x","article-title":". MBL2 and MASP2 gene polymorphisms in patients with hepatocellular carcinoma.","volume":"15","author":"Segat","year":"2008","journal-title":"J Viral Hepat"},{"key":"R10-13-20210129","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1111\/j.1478-3231.2011.02522.x","article-title":". Association of mannose-binding-lectin-2-gene polymorphism with the development of hepatitis-C-induced hepatocellular carcinoma.","volume":"31","author":"Eurich","year":"2011","journal-title":"Liver Int"},{"key":"R11-13-20210129","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1744-313X.1998.tb01146.x","article-title":". Human cytokine gene nucleotide sequence alignments, 1998.","volume":"25","author":"Bidwell","year":"1998","journal-title":"Eur J Immunogenet"},{"key":"R12-13-20210129","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1053\/he.2000.6253","article-title":". Host genetic factors influence disease progression in chronic hepatitis C.","volume":"31","author":"Powell","year":"2000","journal-title":"Hepatology"},{"key":"R13-13-20210129","first-page":"61","article-title":"Course and treatment of recurrent Hepatitis C after liver transplantation.","volume":"50","author":"Neumann","year":"2004","journal-title":"Minerva Gastroenterol Dietol"},{"key":"R15-13-20210129","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1097\/00007890-199905150-00014","article-title":". Outcome of long-term ribavirin therapy for recurrent hepatitis C after liver transplantation.","volume":"67","author":"Cattral","year":"1999","journal-title":"Transplantation"},{"key":"R16-13-20210129","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/01.tp.0000250575.92788.aa","article-title":". Fibrosis progression in hepatitis C positive liver recipients after sustained virologic response to antiviral combination therapy (interferon-ribavirin therapy).","volume":"83","author":"Bahra","year":"2007","journal-title":"Transplantation"},{"key":"R17-13-20210129","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.jhep.2004.06.029","article-title":". Fibrosis progression after liver transplantation in patients with recurrent hepatitis C.","volume":"41","author":"Neumann","year":"2004","journal-title":"J Hepatol"},{"key":"R18-13-20210129","first-page":"337","article-title":"Recurrent allograft disease: Viral hepatitis.","volume":"68","author":"Berenguer","year":"2005","journal-title":"Acta Gastroenterol Belg"},{"key":"R19-13-20210129","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/01.tp.0000268809.86544.22","article-title":". Influence of donor histology on outcome in patients undergoing transplantation for hepatitis C.","volume":"84","author":"Bahra","year":"2007","journal-title":"Transplantation"},{"key":"R20-13-20210129","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1002\/lt.20844","article-title":"Role of cytokine gene polymorphism in recurrent HCV infection after liver transplantation.","volume":"12","author":"Ben-Ari","year":"2006","journal-title":"Liver Transpl"},{"key":"R21-13-20210129","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/hep.24074","article-title":". Interleukin-28B polymorphisms are associated with histological recurrence and treatment response following liver transplantation in patients with hepatitis C virus infection.","volume":"53","author":"Charlton","year":"2011","journal-title":"Hepatology"},{"key":"R22-13-20210129","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0210-5705(03)70363-X","article-title":"Genetic polymorphisms and liver diseases.","volume":"26","author":"Bataller","year":"2003","journal-title":"Gastroenterol Hepatol"},{"key":"R23-13-20210129","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s00109-003-0505-0","article-title":". CC chemokine receptor 5 delta32 polymorphism in two independent cohorts of hepatitis C virus infected patients without hemophilia.","volume":"82","author":"Wasmuth","year":"2004","journal-title":"J Mol Med"},{"key":"R24-13-20210129","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/ng.447","article-title":". IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy.","volume":"41","author":"Suppiah","year":"2009","journal-title":"Nat Genet"},{"key":"R25-13-20210129","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.jhep.2010.07.019","article-title":". IL-28B rs12979860 CT allele distribution in patients with liver cirrhosis: Role in the course of chronic viral hepatitis and the development of HCC.","volume":"54","author":"Fabris","year":"2011","journal-title":"J Hepatol"},{"key":"R26-13-20210129","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nature08309","article-title":". Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance.","volume":"461","author":"Ge","year":"2009","journal-title":"Nature"},{"key":"R27-13-20210129","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.jhep.2010.10.037","article-title":". Impact of donor and recipient IL28B rs12979860 genotypes on hepatitis C virus liver graft reinfection.","volume":"55","author":"Lange","year":"2011","journal-title":"J Hepatol"},{"key":"R28-13-20210129","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/ni873","article-title":". IL-28, IL-29 and their class II cytokine receptor IL-28R.","volume":"4","author":"Sheppard","year":"2003","journal-title":"Nat Immunol"},{"key":"R29-13-20210129","doi-asserted-by":"crossref","first-page":"e1000017","DOI":"10.1371\/journal.ppat.1000017","article-title":". IFN-lambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo.","volume":"4","author":"Sommereyns","year":"2008","journal-title":"PLoS Pathog"},{"key":"R30-13-20210129","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/lt.22080","article-title":". Liver grafts contain a unique subset of natural killer cells that are transferred into the recipient after liver transplantation.","volume":"16","author":"Moroso","year":"2010","journal-title":"Liver Transpl"},{"key":"R31-13-20210129","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0140-6736(01)06102-5","article-title":". Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: A randomised trial.","volume":"358","author":"Manns","year":"2001","journal-title":"Lancet"},{"key":"R32-13-20210129","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/01.tp.0000225827.18034.be","article-title":". Treatment of patients with recurrent hepatitis C after liver transplantation with peginterferon alfa-2B plus ribavirin.","volume":"82","author":"Neumann","year":"2006","journal-title":"Transplantation"},{"key":"R33-13-20210129","first-page":"1","article-title":". Treatment of hepatitis C-virus-reinfection after liver transplant with silibinin in nonresponders to pegylated interferon-based therapy.","volume":"9","author":"Eurich","year":"2011","journal-title":"Exp Clin Transplant"},{"key":"R34-13-20210129","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/lt.22235","article-title":". Association of IL-28b gene polymorphism to histological severity of HCV-induced graft inflammation and response to antiviral therapy.","volume":"17","author":"Eurich","year":"2011","journal-title":"Liver Transpl"},{"key":"R35-13-20210129","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1365-2036.2008.03745.x","article-title":". Longitudinal effects of hepatitis C virus treatment on hepatic mitochondrial dysfunction assessed by C-methionine breath test.","volume":"28","author":"Banasch","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"R36-13-20210129","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0168-8278(96)80234-0","article-title":". Intra-observer and inter-observer variation in the histopathological assessment of chronic viral hepatitis.","volume":"25","author":"Goldin","year":"1996","journal-title":"J Hepatol"},{"key":"R37-13-20210129","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/hep.1840190629","article-title":". Classification of chronic hepatitis: Diagnosis, grading and staging.","volume":"19","author":"Desmet","year":"1994","journal-title":"Hepatology"},{"key":"R38-13-20210129","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/hep.510250328","article-title":"Banff schema for grading liver allograft rejection: An international consensus document.","volume":"25","year":"1997","journal-title":"Hepatology"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00007890-201203270-00013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T15:47:26Z","timestamp":1646236046000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-201203270-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,27]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0b013e318244f774","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3,27]]}}}